Company Encyclopedia
View More
name
HYGEIA HEALTH
06078.HK
Hygeia Healthcare Holdings Co., Limited offers oncology healthcare services in the People's Republic of China. The company owns and operates private for-profit hospitals that offers oncology healthcare services, such as radiotherapy, chemotherapy, surgery, and targeted therapy, as well as cancer diagnosis, treatment, and rehabilitation. It also provides radiotherapy services to third-party hospitals, including radiotherapy center consulting services, licensing of radiotherapy equipment for use in the radiotherapy centers, and maintenance and technical support services for radiotherapy equipment. In addition, the company provides management services to private not-for-profit hospitals, as well as supply chain services; sells pharmaceutical, medical consumables, and medical equipment to third parties; and produces proprietary SRT equipment.
34.20 B
06078.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care FacilitiesIndustry
Industry Ranking2/18
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE6.82%C
    • Profit Margin11.37%B
    • Gross Margin26.57%C
  • Growth ScoreD
    • Revenue YoY-13.60%E
    • Net Profit YoY-37.08%D
    • Total Assets YoY1.31%C
    • Net Assets YoY5.72%B
  • Cash ScoreC
    • Cash Flow Margin879.84%B
    • OCF YoY-13.60%E
  • Operating ScoreC
    • Turnover0.37C
  • Debt ScoreB
    • Gearing Ratio36.95%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    After the stock price has dropped by nearly 90%, is the fundamentally stable HYGEIA HEALTH on the eve of a valuation reversal?

    Under the influence of the DRG policy, HYGEIA HEALTH's revenue and profit have declined, with mid-term revenue expected to decrease by 15%-17% and net profit to drop by 34%-39%. The stock price has fallen from a peak of HKD 109.43 in 2021 to HKD 13.12, a decline of 87.95%. The DRG payment reform has led to a shift in the revenue model of hospitals, putting pressure on the profit margins of private hospitals

    Zhitong·
    HK
    06078
    -0.49%
    Zhitong·
    HK
    06078
    -0.49%

    Positive earnings growth hasn't been enough to get Hygeia Healthcare Holdings (HKG:6078) shareholders a favorable return over the last five years

    Hygeia Healthcare Holdings (HKG:6078) has seen a significant decline in share price, dropping 71% over the past five years and 41% in the last year, despite a 48% annual increase in earnings per share (EPS) and a 24% annual revenue growth. Recent insider buying is a positive sign, but investors are advised to focus on fundamental metrics before making decisions. The stock's poor performance compared to market gains raises concerns about underlying challenges, suggesting a cautious approach for potential investors.

    Simplywall·
    HK
    06078
    -0.49%
    Simplywall·
    HK
    06078
    -0.49%

    Hong Kong Stock Midday Review | Hang Seng Index rose 0.12% in the morning session, with the Macau sector leading the gains

    The Hong Kong Hang Seng Index rose 0.12% in the morning session, reporting 26,576 points, with a turnover of HKD 179 billion. Gaming stocks performed strongly, with August Macau gaming revenue exceeding expectations; Wynn Macau, MELCO INT'L DEV, and Sands China all rose over 5%. Weimob Group rose over 10%, Ganfeng Lithium rose over 10%, and Yangtze Optical Fibre and Cable rose over 12%. Most stablecoin concept stocks rose, with HYGEIA HEALTH rising over 6%. Tesla-related news caused Sanhua Intelligent Control to drop over 7%

    Zhitong·
    HK
    00200
    -2.80%
    HK
    01128
    -0.62%
    HK
    06078
    -0.49%
    Zhitong·
    HK
    00200
    -2.80%
    HK
    01128
    -0.62%
    HK
    06078
    -0.49%

    Understanding the Market | HYGEIA HEALTH rises over 8% as founder Zhu Yiwen increases holdings by 1.6648 million shares

    HYGEIA HEALTH's stock price rose by over 8%, with an increase of 8.14% as of the time of publication, trading at HKD 14.88, with a transaction volume of HKD 339 million. Founder Zhu Yiwen increased his holdings by 1.6648 million shares on September 18, bringing his ownership stake to 46.28%. Although a decline in performance is expected in the first half of 2025, the company's balance sheet shows positive signals, and it is anticipated that it will gradually emerge from the trough in 2026

    Zhitong·
    HK
    06078
    -0.49%
    Zhitong·
    HK
    06078
    -0.49%

    Zhitong Hong Kong Stock Shareholders' Equity Disclosure | September 19

    According to reports from Zhitong Finance APP, on September 19, 2025, YUNFENG FIN, HYGEIA HEALTH, and UBOT HOLDING (08N22069) made the latest shareholder equity disclosures. Key Imagination Limited of YUNFENG FIN reduced its holdings from 1.828 billion shares to 1.636 billion shares, with the shareholding ratio decreasing from 47.25% to 42.30%; Zhu Yiwen of HYGEIA HEALTH slightly increased his holdings to 286 million shares, with a shareholding ratio of 46.28%; Tang Yuantao of UBOT HOLDING maintained his holdings at 360 million shares, with a shareholding ratio of 70.22%

    Zhitong·
    HK
    08529
    0.00%
    HK
    00376
    -1.16%
    HK
    06078
    -0.49%
    Zhitong·
    HK
    08529
    0.00%
    HK
    00376
    -1.16%
    HK
    06078
    -0.49%
    © 2025 Longbridge｜Disclaimer